Your browser doesn't support javascript.
loading
Evaluation of patients with primary immunodeficiency associated with Bacille Calmette-Guerin (BCG)-vaccine-derived complications.
Sohani, M; Habibi, S; Delavari, S; Shahkarami, S; Yazdani, Reza; Shirmast, P; Nazari, F; Moeini Shad, T; Mamishi, S; Azizi, G; Anka, A U; Hassanpour, G; Kalantari, A; Shariat, M; Shafiei, A; Abolhassani, H; Aghamohammadi, A.
Afiliação
  • Sohani M; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran.
  • Habibi S; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran.
  • Delavari S; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran.
  • Shahkarami S; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran; Medical Genetics Network (Megene), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Yazdani R; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran; Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Sciences, Tehran, Iran.
  • Shirmast P; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran.
  • Nazari F; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran.
  • Moeini Shad T; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran.
  • Mamishi S; Pediatric Infectious Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Azizi G; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Anka AU; Department of Medical Laboratory Science, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.
  • Hassanpour G; Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran.
  • Kalantari A; Department of Immunology and Allergy, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Shariat M; Department of Allergy and Clinical Immunology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Shafiei A; The Department of Immunology, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Abolhassani H; Research Center for Primary Immunodeficiencies, Iran University of medical sciences, Tehran, Iran; Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Aghamohammadi A; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran; Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Sciences, Tehran, Iran. Electronic address: aghamohammadi@t
Allergol Immunopathol (Madr) ; 48(6): 729-737, 2020.
Article em En | MEDLINE | ID: mdl-33115608

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina BCG / Doenças da Imunodeficiência Primária / Doença Granulomatosa Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina BCG / Doenças da Imunodeficiência Primária / Doença Granulomatosa Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article